Literature DB >> 12644990

Screening, library-assisted identification and validated quantification of fifteen neuroleptics and three of their metabolites in plasma by liquid chromatography/mass spectrometry with atmospheric pressure chemical ionization.

Carsten Kratzsch1, Frank T Peters, Thomas Kraemer, Armin A Weber, Hans H Maurer.   

Abstract

A liquid chromatographic/mass spectrometric assay with atmospheric pressure chemical ionization (APCI-LC/MS) is presented for the fast and reliable screening and identification and for the precise and sensitive quantification of 15 neuroleptic (antipsychotic) drugs and three of their relevant metabolites in plasma. It allows confirmation of the diagnosis of a neuroleptic overdose and monitoring of psychiatric patients' compliance. The neuroleptics amisulpride, bromperidol, clozapine, droperidol, flupenthixol, fluphenazine, haloperidol, melperone, olanzapine, perazine, pimozide, risperidone, sulpiride, zotepine and zuclopenthixol and the pharmacologically active metabolites norclozapine, clozapine N-oxide and 9-hydroxyrisperidone were extracted from plasma using solid-phase extraction and were separated on a Merck LiChroCART column with Superspher 60 RP Select B as the stationary phase. Gradient elution was performed using aqueous ammonium formate and acetonitrile. After screening and identification in the scan mode using the authors' new LC/MS library, the neuroleptics were quantified in the selected-ion mode. The quantification assay was fully validated. It was found to be selective and proved to be linear from sub-therapeutic to over therapeutic concentrations for all analytes. The corresponding reference levels are listed. The accuracy and precision data were within the required limits. The analytes were stable in frozen plasma for at least 1 month. The method was successfully applied to several authentic plasma samples from patients treated or intoxicated with various neuroleptics. The validated LC/MS assay has proved to be appropriate for the isolation, separation, screening, identification and quantification of various neuroleptics in plasma for clinical toxicology and therapeutic drug monitoring purposes. Copyright 2003 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12644990     DOI: 10.1002/jms.440

Source DB:  PubMed          Journal:  J Mass Spectrom        ISSN: 1076-5174            Impact factor:   1.982


  9 in total

1.  Degradation of zopiclone during storage of spiked and authentic whole blood and matching dried blood spots.

Authors:  Ricarda Jantos; Annemiek Vermeeren; Danica Sabljic; Johannes G Ramaekers; Gisela Skopp
Journal:  Int J Legal Med       Date:  2012-04-25       Impact factor: 2.686

2.  Highly-parallel metabolomics approaches using LC-MS for pharmaceutical and environmental analysis.

Authors:  Sunil Bajad; Vladimir Shulaev
Journal:  Trends Analyt Chem       Date:  2007-06-01       Impact factor: 12.296

3.  Second-derivative synchronous fluorescence spectroscopy for the simultaneous determination of fluphenazine hydrochloride and nortriptyline hydrochloride in pharmaceutical preparations.

Authors:  M I Walash; A El-Brashy; N El-Enany; M E Kamel
Journal:  J Fluoresc       Date:  2009-05-06       Impact factor: 2.217

4.  Development and validation of amisulpride in human plasma by HPLC coupled with tandem mass spectrometry and its application to a pharmacokinetic study.

Authors:  Ramakotaiah Mogili; Kanchanamala Kanala; Balasekhara Reddy Challa; Babu Rao Chandu; Chandrasekhar Kottapalli Bannoth
Journal:  Sci Pharm       Date:  2011-07-25

5.  Selective separation, detection of zotepine and mass spectral characterization of degradants by LC-MS/MS/QTOF.

Authors:  M V N Kumar Talluri; Naveen Reddy Kandimalla; Raju Bandu; Divya Chundi; Ramesh Marupaka; Ragampeta Srinivas
Journal:  J Pharm Anal       Date:  2013-05-28

6.  New Modified UPLC/Tandem Mass Spectrometry Method for Determination of Risperidone and Its Active Metabolite 9-Hydroxyrisperidone in Plasma: Application to Dose-Dependent Pharmacokinetic Study in Sprague-Dawley Rats.

Authors:  Essam Ezzeldin; Marwa Tammam; Nisreen F Abo Talib
Journal:  Int J Anal Chem       Date:  2017-05-03       Impact factor: 1.885

7.  Diagnostic accuracy for drug detection using liquid chromatography/mass spectroscopy in overdose patients.

Authors:  Gen Yagihashi; Takehiko Tarui; Hiroyuki Miyagi; Hiroaki Ohnishi; Takashi Watanabe; Yoshihiro Yamaguchi
Journal:  Acute Med Surg       Date:  2020-01-30

8.  Low dose oral haloperidol does not prolong QTc interval in older acutely hospitalised adults: a subanalysis of a randomised double-blind placebo-controlled study.

Authors:  Edmée Jm Schrijver; Maaike Verstraaten; Peter M van de Ven; Pierre M Bet; Astrid M van Strien; Carel de Cock; Prabath Wb Nanayakkara
Journal:  J Geriatr Cardiol       Date:  2018-06       Impact factor: 3.327

9.  Determination of Chlorpromazine, Haloperidol, Levomepromazine, Olanzapine, Risperidone, and Sulpiride in Human Plasma by Liquid Chromatography/Tandem Mass Spectrometry (LC-MS/MS).

Authors:  Abderrezak Khelfi; Mohammed Azzouz; Rania Abtroun; Mohammed Reggabi; Berkahoum Alamir
Journal:  Int J Anal Chem       Date:  2018-09-02       Impact factor: 1.885

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.